These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 8113996)

  • 1. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
    Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
    J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal development of delta-opioid receptor subtypes in mice.
    Negri L; Severini C; Lattanzi R; Potenza RL; Melchiorri P
    Br J Pharmacol; 1997 Mar; 120(6):989-94. PubMed ID: 9134207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
    Wild KD; Carlisi VJ; Mosberg HI; Bowen WD; Portoghese PS; Sultana M; Takemori AE; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1993 Feb; 264(2):831-8. PubMed ID: 8382281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptors.
    Contreras PC; Tam L; Drower E; Rafferty MF
    Brain Res; 1993 Feb; 604(1-2):160-4. PubMed ID: 8384509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of peptidomimetic delta opioid receptor antagonists using the message-address concept.
    Portoghese PS; Sultana M; Takemori AE
    J Med Chem; 1990 Jun; 33(6):1714-20. PubMed ID: 2160538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors.
    Rogers H; Hayes AG; Birch PJ; Traynor JR; Lawrence AJ
    J Pharm Pharmacol; 1990 May; 42(5):358-9. PubMed ID: 1976787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites.
    Sofuoglu M; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1992 Jun; 216(2):273-7. PubMed ID: 1327813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: further evidence for delta receptor heterogeneity.
    Xu H; Partilla JS; de Costa BR; Rice KC; Rothman RB
    Peptides; 1993; 14(5):893-907. PubMed ID: 8284266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors.
    Wild KD; Horan PJ; Misicka A; Lipkowski A; Haaseth RC; Matsunaga TO; Hruby VJ; Toth G; Borsodi A; Yamamura HI
    Eur J Pharmacol; 1993 Jun; 246(1):25-31. PubMed ID: 8394818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
    Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
    Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a human delta opioid receptor: cloning and expression.
    Knapp RJ; Malatynska E; Fang L; Li X; Babin E; Nguyen M; Santoro G; Varga EV; Hruby VJ; Roeske WR
    Life Sci; 1994; 54(25):PL463-9. PubMed ID: 8201839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of some 7-arylidene and 7-heteroarylidene morphinan-6-ones on the antinociceptive activity of [D-Pen2, D-Pen5]enkephalin and [D-Ala2, Glu4]deltorphin II and on multiple opioid receptors.
    Bhargava HN; Zhao GM; Bian JT; Nan Y; Upadhyaya SP; Xu W; Dunn WJ; Bauer L
    Peptides; 1997; 18(5):695-701. PubMed ID: 9213363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene.
    Maldonado R; Severini C; Matthes HW; Kieffer BL; Melchiorri P; Negri L
    Br J Pharmacol; 2001 Apr; 132(7):1485-92. PubMed ID: 11264242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of BW 373U86, a non-peptidic delta opioid receptor agonist, is not regulated by guanine nucleotides and sodium.
    Wild KD; Fang L; McNutt RW; Chang KJ; Toth G; Borsodi A; Yamamura HI; Porreca F
    Eur J Pharmacol; 1993 Aug; 246(3):289-92. PubMed ID: 8223952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of opioid peptides and other drugs with multiple delta ncx binding sites in rat brain: further evidence for heterogeneity.
    Xu H; Partilla JS; de Costa BR; Rice KC; Rothman RB
    Peptides; 1992; 13(6):1207-13. PubMed ID: 1337380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
    Cao YJ; Bian JT; Bhargava HN
    Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.